Simplex Trading’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-37,462
| Closed | -$1.14M | – | 9188 |
|
|
2026
Q1 | $1.27M | Buy |
37,462
+31,253
| +503% | +$886K | ﹤0.01% | 2250 |
|
|
2025
Q4 | $169K | Buy |
+6,209
| New | +$218K | ﹤0.01% | 4403 |
|
|
2023
Q4 | – | Sell |
-21,006
| Closed | -$471K | – | 8675 |
|
|
2023
Q3 | $519K | Buy |
21,006
+9,552
| +83% | +$253K | ﹤0.01% | 3356 |
|
|
2023
Q2 | $324K | Sell |
11,454
-3,380
| -23% | -$84.1K | ﹤0.01% | 3746 |
|
|
2023
Q1 | $340K | Buy |
+14,834
| New | +$394K | ﹤0.01% | 3679 |
|
|
2022
Q4 | – | Sell |
-15,807
| Closed | -$445K | – | 9082 |
|
|
2022
Q3 | $447K | Buy |
15,807
+5,997
| +61% | +$161K | ﹤0.01% | 3591 |
|
|
2022
Q2 | $217K | Buy |
+9,810
| New | +$222K | ﹤0.01% | 4499 |
|
|
2022
Q1 | – | Sell |
-4,260
| Closed | -$130K | – | 10277 |
|
|
2021
Q4 | $140K | Sell |
4,260
-1,455
| -25% | -$58.6K | ﹤0.01% | 5702 |
|
|
2021
Q3 | $322K | Sell |
5,715
-1,607
| -22% | -$77.6K | ﹤0.01% | 4792 |
|
|
2021
Q2 | $403K | Buy |
+7,322
| New | +$409K | ﹤0.01% | 4491 |
|
|
2021
Q1 | – | Sell |
-13,337
| Closed | -$660K | – | 8666 |
|
|
2020
Q4 | $577K | Buy |
13,337
+11,422
| +596% | +$452K | ﹤0.01% | 3234 |
|
|
2020
Q3 | $67K | Sell |
1,915
-268
| -12% | -$11.7K | ﹤0.01% | 5319 |
|
|
2020
Q2 | $116K | Buy |
+2,183
| New | +$101K | ﹤0.01% | 4647 |
|
|
2019
Q4 | – | Sell |
-27,037
| Closed | -$1.02M | – | 7203 |
|
|
2019
Q3 | $875K | Buy |
+27,037
| New | +$1.12M | ﹤0.01% | 2063 |
|
|
2019
Q2 | – | Sell |
-1,133
| Closed | -$60.6K | – | 7009 |
|
|
2019
Q1 | $76K | Sell |
1,133
-9,742
| -90% | -$567K | ﹤0.01% | 4614 |
|
|
2018
Q4 | $501K | Buy |
10,875
+6,457
| +146% | +$399K | ﹤0.01% | 2226 |
|
|
2018
Q3 | $340K | Sell |
4,418
-20,260
| -82% | -$1.63M | ﹤0.01% | 3027 |
|
|
2018
Q2 | $2.08M | Buy |
24,678
+8,444
| +52% | +$736K | 0.01% | 1097 |
|
|
2018
Q1 | $1.33M | Buy |
16,234
+9,240
| +132% | +$714K | 0.06% | 290 |
|
|
2017
Q4 | $399K | Buy |
6,994
+6,957
| +18,803% | +$438K | 0.02% | 835 |
|
|
2017
Q3 | $2K | Buy |
+37
| New | +$2.22K | ﹤0.01% | 4984 |
|
|
2017
Q1 | – | Sell |
-354
| Closed | -$17K | – | 6065 |
|
|
2016
Q4 | $14K | Sell |
354
-27,551
| -99% | -$1.45M | ﹤0.01% | 3364 |
|
|
2016
Q3 | $1.47M | Buy |
27,905
+15,604
| +127% | +$680K | 0.1% | 184 |
|
|
2016
Q2 | $515K | Buy |
12,301
+2,368
| +24% | +$117K | 0.03% | 508 |
|
|
2016
Q1 | $403K | Buy |
9,933
+9,812
| +8,109% | +$419K | 0.03% | 533 |
|
|
2015
Q4 | $7K | Buy |
+121
| New | +$7.94K | ﹤0.01% | 3582 |
|
|
2015
Q3 | – | Sell |
-1,130
| Closed | -$110K | – | 5429 |
|
|
2015
Q2 | $125K | Buy |
+1,130
| New | +$122K | 0.01% | 1078 |
|
|
2015
Q1 | – | Sell |
-128
| Closed | -$14.3K | – | 4890 |
|
|
2014
Q4 | $14K | Buy |
+128
| New | +$11.4K | ﹤0.01% | 2307 |
|
Other funds holding AGIO
FCM
LCM
AC
EAM
NAMI
Simplex Trading's AGIO Position: Q2 2026 in Review
Simplex Trading sold out of Agios Pharmaceuticals (AGIO) in Q2 2026, closing a stake of 37,462 shares — an estimated $1.14M sold.
Simplex Trading first reported a position in AGIO in Q4 2014 and held it in 28 quarters. The position peaked at $2.08M in Q2 2018. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.
- Simplex Trading reported no remaining Agios Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 37,462 Agios Pharmaceuticals shares in Q2 2026, an estimated $1.14M.
- Simplex Trading first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 28 quarters.
- Simplex Trading's Agios Pharmaceuticals position peaked at $2.08M in Q2 2018.
- 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.